September 20-21, 2021
The Food Allergy & Anaphylaxis Connection Team (FAACT) cordially invites you to attend its Virtual Seventh Annual Global Food Industry & Research Summit, a two-day summit focused on best practices for food allergy management within the food industry and food science, including the latest in food allergy research, and more.
October 18-20, 2021
FARE’s Contains: Courage® Research Retreat 2021 will bring together clinicians, industry representatives, and investigators in academia and public service to share and learn about the latest advancements in food allergy biology, treatment, prevention and patient-centered care.
This virtual event will feature three days of presentations and live question and answer sessions with key medical experts and researchers sharing the newest data and research in the food allergy space.
November 4-8, 2021
Experts in the field of allergy/immunology, dermatology, pulmonology, and otolaryngology will cover a broad range of topics to choose from. There is something for everyone – clinicians, academicians, fellows-in-training, allied health professionals, office managers and support staff.
Exciting session topics include climate effects on allergy, ICS/SABA vs ICS/LABA for mild asthma, 7 for 11 pediatric update, oral immunotherapy in private practice, and many others!
January 9-14, 2022
The 2022 Food Allergy Gordon Conference will focus on emerging science in food allergy obtained from mouse models, human immunology, and clinical trials. This conference will highlight advances in our understanding of immune mechanisms of allergy and tolerance to foods. Novel areas of concentration include key systems that interact with and shape immunity, including microbiome, the nervous system, and the neuroendocrine system. We will also highlight science supporting emerging treatment approaches for food allergy.
January 10-12, 2022
The 2022 Biotech Showcase program will include in-person sessions January 10–12, 2022 in San Francisco. Select program sessions will be released on our proprietary partneringONE® platform as early as mid-December.
Going live nearly two years after the COVID-19 pandemic first started, the 2022 program will feature insights from top investors and biopharma executives by:
Examining how the biopharma industry can accelerate drug discovery and manufacturing to prepare for future pandemics.
Providing updates in hot therapeutic areas such as oncology, CNS, cell and gene therapy, rare disease.
Exploring how COVID-19 accelerated the adoption of all things digital through the Digital Medicine & Medtech Showcase program.
Showcasing the promise of early-stage innovation through the Seed Showcase program.
February 25-28, 2022
Registration available in October
June 16-17, 2021
Join us for the inaugural Annual Meeting of the Institute for the Advancement of Food and Nutrition Sciences! Leveraging our operative model focused on collaboration and inclusion across industry, government, and academic scientists, sessions will highlight and explore:
July 20-22, 2021
The Next Generation Food Allergy Drug Development Summit will unite large pharma and innovative biotechs to overcome the unique drug development challenges involved in turning promising food allergy biologics into clinical and commercial realities.
These presentations are provided for educational purposes only. While the abstracts were accepted for presentation at medical congresses, these have not been subjected to full peer review and present only initial, preliminary findings, which may differ from those that could appear in later, complete manuscripts and peer-reviewed publications.
January 11-15, 2021
Presentation: AllerGenis Allergy Diagnostic Company Presents Significant Milestones at the 2021 Biotech Showcase™
November 13-15, 2020
Oral Abstract Presentation: 8113-Specific Peanut Epitopes as a Biomarker for Desensitization During Epicutaneous Immunotherapy (abstract #A044)
Date: Saturday, Nov 14, 2020
Time: 3:00 PM - 4:30 PM (CST)
June 6-8, 2020
Thematic Poster Presentation: Repeated validation of a high-performing peanut allergy diagnostic on POISED trial subjects (abstract #711)
Late Breaking Oral Abstract Presentation: Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations (abstract #1776)